The National Psoriasis Foundation (NPF) is offering Bridge Grants to support researchers who have submitted meritorious but unfunded K-type (career development) and R-type applications to the National Institutes of Health (NIH), or similar funding body, with a focus on psoriatic disease or related comorbidities. In addition, NPF is expanding eligibility to include late-stage trainees or newly appointed faculty that have experienced COVID-19 related hardships due to research delays or hiring freezes. Through this special opportunity, NPF provides a critical year of additional support until additional funding can be secured. In line with NPF’s mission, Bridge Grants will provide an important life-line to help support long-term careers of psoriatic disease researchers who will go on to make discoveries that bring us closer to a cure for psoriatic disease and improve patients’ lives.
The principal investigator must be personally and actively responsible for the conduct of the proposed research, and eligible to apply for research grants under the guidelines of the applicant’s host institution. The project proposed must have been submitted as an unfunded application for either a K-type or R-type (or equivalent) award focused on psoriasis, psoriatic arthritis, or related comorbidities.
Budget and Project Period
Applicants may request up to $50,000 (direct costs only) for K-type bridge or COVID-19 related hardships or up to $100,000 for R-type bridge (direct costs only) per year. The total project period for the application submitted is one year.
Information for the 2022 application cycle of funding opportunities will be released in the fall.